​

Axsome Therapeutics Ownership | Who Owns Axsome Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Axsome Therapeutics Ownership Summary

Axsome Therapeutics is owned by 76.51% institutional investors, 16.09% insiders, and 7.40% retail investors. Vanguard group is the largest institutional shareholder, holding 8.46% of AXSM shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.69% of its assets in Axsome Therapeutics shares.

AXSM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAxsome Therapeutics76.51%16.09%7.40%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group4.18M8.46%$507.74M
Blackrock funding, inc. /de3.79M7.67%$460.41M
Blackrock3.30M6.96%$265.65M
Bvf inc/il1.69M3.42%$176.44M
Rtw investments, lp1.52M3.07%$158.35M
Fmr1.00M2.08%$84.65M
Geode capital management997.70K2.02%$121.19M
Macquarie group964.05K2.00%$81.57M
State street947.25K1.97%$80.15M
Fairmount funds management815.18K1.65%$85.10M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management734.32K53.19%$62.13M
Svb capital management33.85K12.95%$4.11M
Fairmount funds management815.18K11.02%$85.10M
Bvf inc/il1.69M6.30%$176.44M
Tri locum partners lp249.77K4.38%$21.13M
Pfm health sciences, lp483.11K4.33%$50.43M
Iridian asset management llc/ct83.55K3.99%$10.15M
Ghost tree capital150.00K3.78%$12.07M
Nationale-nederlanden powszechne towarzystwo emerytalne326.32K3.06%$39.63M
First turn management118.18K2.78%$13.78M

Top Buyers

HolderShares% AssetsChange
Deep track capital, lp801.37K2.68%801.37K
Norges bank403.03K0.00%403.03K
Adage capital partners gp447.00K0.08%399.00K
Hood river capital management371.10K0.54%371.10K
Vanguard group4.18M0.01%235.63K

Top Sellers

HolderShares% AssetsChange
Rtw investments, lp1.52M2.26%-1.41M
Ra capital management---1.00M
Morgan stanley321.98K0.00%-621.90K
1832 asset management---363.20K
Vestal point capital, lp---300.00K

New Positions

HolderShares% AssetsChangeValue
Deep track capital, lp801.37K2.68%801.37K$83.66M
Norges bank403.03K0.00%403.03K$34.10M
Man group163.39K0.04%163.39K$13.82M
Blackstone140.00K0.06%140.00K$14.61M
Squarepoint ops89.43K0.01%89.43K$7.57M

Sold Out

HolderChange
Financial gravity asset management-1.00
Geowealth management-5.00
Allspring global investments-9.00
Capital performance advisors llp-10.00
Nelson, van denburg & campbell wealth management group-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025365-3.18%37,827,2692.24%761.33%2069.57%89-25.21%
Mar 31, 202519-94.14%7,027,292-81.11%140.24%8-94.97%9-90.00%
Dec 31, 20243193.57%37,149,265-2.97%771.22%15315.04%90-1.10%
Sep 30, 202430712.45%38,233,493-6.12%791.08%13115.93%93-1.06%
Jun 30, 2024271-3.21%40,700,3596.09%851.20%112-17.04%9317.72%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.31M2.69%114.89K
Vanguard Total Stock Mkt Idx Inv1.24M2.48%-25.86K
iShares Russell 2000 ETF973.92K1.95%-
Vanguard Small Cap Index955.65K1.92%-7.08K
Macquarie Small Cap Core I651.89K1.31%-48.97K
Delaware Small Cap Core I579.64K1.21%-3.59K
Vanguard Small Cap Growth Index Inv539.73K1.08%-181.00
Bellevue Healthcare Ord506.57K1.06%506.57K
Vanguard Institutional Extnd Mkt Idx Tr444.16K0.89%-196.42K
Fidelity Small Cap Index405.99K0.81%32.79K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 04, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$6.75M
Nov 05, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$2.93M
Nov 03, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$12.14M
Oct 06, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$2.31M
Oct 07, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$1.59M

Insider Transactions Trends

DateBuySell
2025 Q4-6
2025 Q3313
2025 Q2-11
2025 Q1-2
2024 Q4--

AXSM Ownership FAQ

Who Owns Axsome Therapeutics?

Axsome Therapeutics shareholders are primarily institutional investors at 76.51%, followed by 16.09% insiders and 7.40% retail investors. The average institutional ownership in Axsome Therapeutics's industry, Biotech Stocks , is 295.31%, which Axsome Therapeutics falls below.

Who owns the most shares of Axsome Therapeutics?

Axsome Therapeutics’s largest shareholders are Vanguard group (4.18M shares, 8.46%), Blackrock funding, inc. /de (3.79M shares, 7.67%), and Blackrock (3.3M shares, 6.96%). Together, they hold 23.09% of Axsome Therapeutics’s total shares outstanding.

Does Blackrock own Axsome Therapeutics?

Yes, BlackRock owns 6.96% of Axsome Therapeutics, totaling 3.3M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 265.65M$. In the last quarter, BlackRock increased its holdings by 104.5K shares, a 3.27% change.

Who is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested, with 53.19% of its assets in 734.32K Axsome Therapeutics shares, valued at 62.13M$.

Who is the top mutual fund holder of Axsome Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Axsome Therapeutics shares, with 2.69% of its total shares outstanding invested in 1.31M Axsome Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools